- Added Creapure – the undisputed best!
A Closer Look at the Changes
Now you will get a pump on top of your pump! With Creapure – less is more than all the rest
Recent science has revealed that not all raw materials for creatine monohydrate are created equal. And since dotFIT follows the Practitioner Product guidelines, we’ve made the switch to the undisputed best. It’s called Creapure,® which is made in Germany where dietary supplements are tightly regulated. (We’ll make the same changes with our Creatine Monohydrate powder on the next production run).
When comparing all other creatine raw materials, scientists found too much was wasted as creatinine (a harmless but also useless byproduct) not just in the raw material itself but also during digestion, meaning the availability for complete absorption was limited. This is not the case as you can see in Figures 1 and 2 below comparing Creapure® to the impurities found in inferior types of creatine. In other words, more pure creatine, less creatinine.
Pure creatine monohydrate (Creapure®) during digestion remains stable and is almost fully available to the body (Figure 2). Inferior raw materials or a too-rapid reduction in the amount of water during “recrystallization” results in higher amounts of creatinine, dicyandiamide, and dihydrotriazine (Figure 1) thus less creatine availability. Typical analytical values for Creapure®:
- Creatine monohydrate: min. 99.95%
- Creatinine <67 ppm
- Dicyandiamide (DCD): not detectable
- Dihydrotriazine: not detectable
Figure 2 One time ingestion of Creapure® (5gms) results in markedly elevated plasma creatine levels without raising creatinine levels
Questions about the new Creatine XXL? Call us at 877.436.8348 between the hours of 8 am and 5 pm Pacific Time, Monday through Friday, or email us at Experts@dotFIT.com.
Nutrition can help you and your family Grow Strong.
Yours in Health,
The dotFIT Team
 M. Hageböck, U. Stahl, J. Bader, Stability of creatine derivatives during simulated digestion in an in vitro model, Food Funct., 2014, 5, 359-363, DOI: 10.1039/C3FO60453E.